Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic

Int Immunopharmacol
09 November 2022
https://pubmed.ncbi.nlm.nih.gov/36379151/

Low Dose Naltrexone (LDN) Increases Endorphin Levels (News)

Submitted by baileylynn_100964 on Thu, 10/06/2022 - 07:14

Low Dose Naltrexone (LDN) Increases Endorphin Levels

RecentlyHeard
30 September 2022
https://recentlyheard.com/2022/09/30/low-dose-naltrexone-ldn-increases-endorphin-levels/

When prescribed in the low dose form, LDN can help with a multitude of different ailments and issues such as anxiety, depression, inflammation, cancers, chronic pain, immune system dysfunction, and other mental health-related issues, as well.  

A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder

Trials
30 September 2022
https://pubmed.ncbi.nlm.nih.gov/36175917/